Sawgrass Asset Management LLC Innoviva, Inc. Transaction History

Sawgrass Asset Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 07, 2019	SELL	$13.69 - $20.06 $308,914 - $452,653	-22,565 Closed	0 $0
Q4 2018 Feb 01, 2019	BUY	$13.96 - $18.26 $315,007 - $412,036	22,565 New	22,565 $394,000
Q3 2018 Nov 19, 2018	SELL	$13.63 - $15.7 $736,428 - $848,271	-54,030 Closed	0 $0
Q2 2018 Jul 26, 2018	SELL	$13.44 - $17.59 $2.23 Million - $2.92 Million	-165,975 Reduced 75.44%	54,030 $746,000
Q1 2018 May 15, 2018	BUY	$13.8 - $16.99 $736,299 - $906,501	53,355 Added 32.02%	220,005 $3.67 Million
Q4 2017 Feb 12, 2018	BUY	$11.73 - $14.75 $1 Million - $1.26 Million	85,305 Added 104.87%	166,650 $2.37 Million
Q3 2017 Nov 09, 2017	BUY	$12.06 - $14.12 $981,020 - $1.15 Million	81,345	81,345 $1.15 Million

229

79.2M

37.6K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.33B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Sawgrass Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Sawgrass Asset Management LLC with notifications on news.